Clinical Trial

Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease

Name: Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease — clinical trial record (NCT07292012)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EMINENT-CD

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Efficacy of Mirikizumab to achieve transmural healing in patients with Crohn's Disease

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-05.

Status change: Not Yet Recruiting → Recruiting 2026-05-21

Trial Details

NCT Number	NCT07292012
Lead Sponsor	Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Conditions	Crohn Disease (CD)
Enrollment	75 participants
Start Date	2026-05-11
Primary Completion	2027-11 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2026-05-26